Mergers & acquisitions

Fast Takes on Talent Innovations

02/05/16

Our series of Fast Takes on Talent Innovations examines the critical role each element of the talent ecosystem plays within an organization – and offers PwC’s insights on how today’s business leaders can reinvent their talent strategies to compete and win.

2015 Annual US Capital Markets Watch

02/03/16

2015 Annual US Capital Markets Watch: Analysis and trends

Energy Deals: Fourth-quarter 2015 oil and gas industry mergers and acquisitions analysis

02/02/16

Energy deals is PwC's quarterly analysis of merger and acquisition (M&A) activity in the US oil and gas industry. It provides an overview of the most recent M&A results and our expectations for future deal activity.

US banking deals insights - 2015 update and outlook for 2016

02/01/16

In 2015, deal values greater than $1 billion made up 76% of all deal value, marking the return of large deals to pre-Financial Crisis levels. Deals in 2015 raised approximately $1 billion from 12 IPOs, down 93% in value from 2014.

Transaction Trends in Oil and Gas: Full year M&A update - Webcast replay

01/28/16

In this recorded webcast, we discuss the trends and drivers of oil and gas deal activity and capital market activity in 2015.

In the loop: Spin-off transactions - Governance considerations

01/06/16

Spin-offs have seen a resurgence in recent years. Learn about the governance issues associated with these transactions.

PwC’s Deals Practice: Year-end M&A Outlook for 2016 - Webcast replay

12/18/15

Watch this recorded webcast to review the current state of the M&A market in the US, the trends impacting dealmaking, what we envision the deal market could look like in 2016, and key considerations for successfully executing your deal.

Podcast: Restructuring

11/22/15

Changes in the business landscape can result in personnel restructuring or exiting leased facilities. Listen now to learn more.

Pharmaceutical and Life Sciences Deals Insights Quarterly Q3 2015

11/17/15

After a record second quarter, the pharmaceutical and life sciences (PLS) industry continued to demonstrate a healthy deal value and volume in the third quarter. Closed deal volume increased from the prior quarter to 59 from 46 transactions, with deal value decreasing to $67.6 billion from $72.2 billion. Announced and pending transactions continued to shine at $118.9 billion in deal value and 110 transactions.

M&A talent strategy: Engaging and retaining talent

11/17/15

Achieving success in M&A requires evaluating leaders and teams, understanding what motivates them, and an ability to design incentives, environments, and roles with the goal of retaining the most valuable talent.